Checkmate Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
43
- Portfolio
-
25
- Exits
-
16
Checkmate Capital General Information
Company Description
Founded in 2017, Checkmate Capital is a venture capital firm based in Pasadena, California. The firm seeks to invest primarily in North American companies operating in biotechnology, agriculture, waste technology, and energy technology sectors.
Business Details
Website
www.checkmatecapital.netYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 595 East Colorado Boulevard
- Suite 530
- Pasadena, CA 91101
- United States
Checkmate Capital Investments & Acquisitions (43)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| NeuroSigma | 15-Dec-2025 | Later Stage VC | Other Devices and Supplies | Generating Revenue | ||
| Hopewell Therapeutics | 16-Sep-2025 | Drug Delivery | Generating Revenue | |||
| Austrianova Singapore | 01-Jan-2025 | Drug Delivery | Generating Revenue | |||
| Markable | 06-Jun-2024 | Media and Information Services (B2B) | Profitable | |||
| HepaTx | 12-Apr-2024 | Drug Discovery | Pre-Clinical Trials | |||
| Radiance Therapeutics | 28-Jun-2023 | Surgical Devices | Out of Business | |||
| Bredis Healthcare | 19-May-2023 | Diagnostic Equipment | Generating Revenue | |||
| Austrianova Singapore | 01-Mar-2023 | Drug Delivery | Generating Revenue | |||
| HyperSciences | 23-Jan-2023 | Later Stage VC | Construction and Engineering | Generating Revenue | ||
| Altis Biosystems | 22-Sep-2022 | Later Stage VC | Biotechnology | Generating Revenue |
Checkmate Capital Exits (16)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Radiance Therapeutics | 28-Oct-2026 | Out of Business | |
| Community Eco Power | 05-Feb-2026 | ||
| Coya Therapeutics | 27-Oct-2025 | ||
| Rancho Santa Fe Bio | 01-Jun-2024 | ||
| QSAM Biosciences | 03-May-2024 | ||
| TRUEFILL | 23-Apr-2024 | ||
| Coya Therapeutics | 29-Dec-2022 | ||
| MAIA Biotechnology | 28-Jul-2022 | ||
| 20/20 BioLabs | 08-Sep-2021 | IPO | |
| Schrodinger | 06-Feb-2020 | IPO |
Checkmate Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Checkmate Capital Co-Investors (63)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Bayer | 1 |
|
|
||
| Headline |
|
|
|||
| NEC (IT Consulting and Outsourcing) |
|
|
|||
| Partech |
|
|
|||
| University of Michigan Endowment |
|
|
Checkmate Capital FAQs
-
What is Checkmate Capital?
Founded in 2017, Checkmate Capital is a venture capital firm based in Pasadena, California.
-
When was Checkmate Capital founded?
Checkmate Capital was founded in 2017.
-
Where is Checkmate Capital headquartered?
Checkmate Capital is headquartered in Pasadena, CA.
-
How many investments has Checkmate Capital made?
Checkmate Capital has made 43 investments.
-
What has Checkmate Capital invested in?
Checkmate Capital has made numerous investments in companies like NeuroSigma, Hopewell Therapeutics, and Austrianova Singapore within the Devices and Supplies and Drug Delivery industries.
-
What has Checkmate Capital invested in recently?
Checkmate Capital's latest investment was on 15-Dec-2025 in NeuroSigma, a company within the Devices and Supplies industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
